S100A1 and amyotrophic lateral sclerosis: Significant decrease in anti-S100 immunoreactivity at NMJs in both EOMs and limb muscles of ALS donors were confirmed on muscles from SOD1G93A mice at terminal stage (Figure 5B, 5D).